These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2157768)
21. Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. Magnani M; Fraternale A; Casabianca A; Schiavano GF; Chiarantini L; Palamara AT; Ciriolo MR; Rotilio G; Garaci E AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1093-9. PubMed ID: 9282814 [TBL] [Abstract][Full Text] [Related]
22. ZDV delays but does not prevent the transmission of MAIDS by LP-BM5 MuLV-infected macrophage-monocytes. Bilello JA; Kort JJ; MacAuley C; Fredrickson TN; Yetter RA; Eiseman JL J Acquir Immune Defic Syndr (1988); 1992; 5(6):571-6. PubMed ID: 1316959 [TBL] [Abstract][Full Text] [Related]
23. The Effects of Curcuma longa L., Purple Sweet Potato, and Mixtures of the Two on Immunomodulation in C57BL/6J Mice Infected with LP-BM5 Murine Leukemia Retrovirus. Park SJ; Lee D; Lee M; Kwon HO; Kim H; Park J; Jeon W; Cha M; Jun S; Park K; Lee J J Med Food; 2018 Jul; 21(7):689-700. PubMed ID: 29862890 [TBL] [Abstract][Full Text] [Related]
24. Effect of cyclosporin A and zidovudine on immune abnormalities observed in the murine acquired immunodeficiency syndrome. Cerny A; Merino R; Fossati L; de Kossodo S; Heusser C; Waldvogel FA; Morse HC; Izui S J Infect Dis; 1992 Aug; 166(2):285-90. PubMed ID: 1634800 [TBL] [Abstract][Full Text] [Related]
25. Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics. Brundu S; Palma L; Picceri GG; Ligi D; Orlandi C; Galluzzi L; Chiarantini L; Casabianca A; Schiavano GF; Santi M; Mannello F; Green K; Smietana M; Magnani M; Fraternale A J Virol; 2016 Aug; 90(16):7118-7130. PubMed ID: 27226373 [TBL] [Abstract][Full Text] [Related]
26. Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection. Morrey JD; Warren RP; Okleberry KM; Burger RA; Johnston MI; Sidwell RW J Acquir Immune Defic Syndr (1988); 1990; 3(5):500-10. PubMed ID: 2157836 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of murine AIDS by a new azidothymidine homodinucleotide. Magnani M; Casabianca A; Fraternale A; Brandi G; Chiarantini L; Benatti U; Scarfì S; Millo E; De Flora A J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):189-95. PubMed ID: 9495216 [TBL] [Abstract][Full Text] [Related]
28. Testing of nucleoside analogues in cats infected with feline leukemia virus: a model. Tavares L; Roneker C; Postie L; de Noronha F Intervirology; 1989; 30 Suppl 1():26-35. PubMed ID: 2540111 [TBL] [Abstract][Full Text] [Related]
29. Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice. Sasaki H; Kobayashi M; Pollard RB; Suzuki F Pathobiology; 2001; 69(2):96-103. PubMed ID: 11752903 [TBL] [Abstract][Full Text] [Related]
30. Zidovudine (azido dideoxythymidine) inhibits characteristic early alterations of lymphoid cell populations in retrovirus-induced murine AIDS. Portnoi D; Stall AM; Schwartz D; Merigan TC; Herzenberg LA; Basham T J Immunol; 1990 Mar; 144(5):1705-10. PubMed ID: 1968486 [TBL] [Abstract][Full Text] [Related]
31. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice. Chow FP; Zsebo K; Hamburger AW Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220 [TBL] [Abstract][Full Text] [Related]
32. Immunomodulatory and Antioxidant Effects of Purple Sweet Potato Extract in LP-BM5 Murine Leukemia Virus-Induced Murine Acquired Immune Deficiency Syndrome. Kim OK; Nam DE; Yoon HG; Baek SJ; Jun W; Lee J J Med Food; 2015 Aug; 18(8):882-9. PubMed ID: 26076116 [TBL] [Abstract][Full Text] [Related]
33. New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS. Fraternale A; Tonelli A; Casabianca A; Chiarantini L; Schiavano GF; Celeste AG; Magnani M J Acquir Immune Defic Syndr; 2000 Feb; 23(2):107-13. PubMed ID: 10737424 [TBL] [Abstract][Full Text] [Related]
34. Effective therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate. Hersh EM; Funk CY; Ryschon KL; Petersen EA; Mosier DE AIDS Res Hum Retroviruses; 1991 Jun; 7(6):553-61. PubMed ID: 1657074 [TBL] [Abstract][Full Text] [Related]
35. Liposomal encapsulation of 3'-azido-3'-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosuppression. Phillips NC; Skamene E; Tsoukas C J Acquir Immune Defic Syndr (1988); 1991; 4(10):959-66. PubMed ID: 1890605 [TBL] [Abstract][Full Text] [Related]
36. Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice. Falcone A; Darnowski JW; Ruprecht RM; Chu SH; Brunetti I; Calabresi P Blood; 1990 Dec; 76(11):2216-21. PubMed ID: 2257295 [TBL] [Abstract][Full Text] [Related]
37. Sustained elevation of platelet counts by long-term azidothymidine treatment of immunosuppressed mice. Chow FP; Chen RB; Hamburger AW J Lab Clin Med; 1993 Apr; 121(4):562-9. PubMed ID: 8454938 [TBL] [Abstract][Full Text] [Related]
38. The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome. Green KA; Okazaki T; Honjo T; Cook WJ; Green WR J Virol; 2008 Mar; 82(5):2456-69. PubMed ID: 18094175 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine. Rossi L; Serafini S; Franchetti P; Casabianca A; Orlandi C; Schiavano GF; Carnevali A; Magnani M J Antimicrob Chemother; 2002 Nov; 50(5):639-47. PubMed ID: 12407119 [TBL] [Abstract][Full Text] [Related]
40. Dose response and timing effects in the therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate. Hersh EM; Funk CY; Petersen EA; Ryschon KL; Mosier DE Int J Immunopharmacol; 1993 Feb; 15(2):137-43. PubMed ID: 8385652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]